🔎 Trials Near Me

Inicio › Cáncer de cuello uterino › Nueva York

Ensayos clínicos de Cáncer de cuello uterino en Nueva York

24 estudios sobre Cáncer de cuello uterino buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5039), Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6009), New York
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 6 nov 2026 · NCT07216703

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • Maimonides Medical Center, Brooklyn
  • Columbia University Medical Center - Herbert Irving Pavilion, New York
  • IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
ReclutandoFase 4
Edades de 18 en adelante · Mujeres · Actualizado el 5 nov 2026 · NCT06952660

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • The Woman's Health Pavilion, Howard Beach
  • The Woman's Health Pavilion, Westbury
ReclutandoEstudio observacional
Edades de 18 en adelante · Mujeres · Actualizado el 5 nov 2026 · NCT05051722

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • y 2 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06465069

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • NYU Langone Health - Long Island, Mineola
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
  • Clinical Research Alliance, Inc, Westbury
  • y 1 más
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06330064

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute IDS, Buffalo
  • Memorial Sloan Kettering Hospital, New York
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 107, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT05914116

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

  • Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
  • Columbia University, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT04977453

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07749586

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Start (Nyli), Lake Success
  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 21 sept 2026 · NCT06925724

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Memorial Sloan Kettering Cancer Center Head Neck Services, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  • Research Site, New York
  • Research Site, Stony Brook
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06535607

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT07227168

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center-Weiler Hospital, The Bronx
ReclutandoSe aceptan voluntarios sanos
Edades de 25 en adelante · Mujeres · Actualizado el 31 jul 2026 · NCT07281430

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • Northwell Health/South Shore University Hospital, Bay Shore
  • Northwell Health Physician Partners/Gynecological Oncology at Brightwaters, Brightwaters
  • Laura and Issac Perlmutter Cancer Center at NYU Langone, Brooklyn
  • y 15 más
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 30 jul 2026 · NCT04831580

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
  • y 7 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632

Emergency Department-based Cervical Cancer Screening Through Self-sampling

  • University of Rochester Strong Memorial Hospital, Rochester
ReclutandoSe aceptan voluntarios sanos
Edades de 30 a 65 · Mujeres · Actualizado el 4 may 2026 · NCT07345897

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • y 2 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers

  • Lenox Hill Hospital, New York
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 23 sept 2025 · NCT05606133

NYSCF Scientific Discovery Biobank

  • New York Stem Cell Foundation Research Institute, New York
ReclutandoEstudio observacional
30 Days · Todos los sexos · Actualizado el 3 mar 2025 · NCT06203106

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.